AbbVie (ABBV) just caught a fresh tailwind after HSBC bumped the stock to a Buy, a move that comes on top of strong quarterly ...

After trailing broader equities over the past few years, will the healthcare sector finally bounce back in 2026? It's hard to ...

In an increasingly uncertain market, where concentration risk looms large, savvy investors are seeking refuge in quality blue-chip stocks. With about 50% of the market's earnings stemming from the top ...

Portfolio manager highlights AbbVie, Pfizer and Medtronic as compelling large-cap health care dividend plays with growth and ...

Migraines. Those who do not have them will never truly understand them. The pain. The fog. The effects they can cause, the way they steal hours, sometimes days, from a life. For Gabrielle Mazzaro, ...

SafeRide Health reports that Ronald McDonald House provides a supportive environment for families of sick children, offering ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...

For those and other reasons, targeted oral therapies like Bruton tyrosine kinase inhibitors (BTKis) and the BCL-2 inhibitor ...

Quick Read Schwab US Dividend Equity ETF (SCHD) has lagged tech funds during the AI boom due to minimal exposure to growth ...

Discover a diversified portfolio of ETFs & CEFs for 6%+ income yield, market-matching growth, and lower tech risk.